Institutional investors purchased a net $22.4 million shares of TEVA during the quarter ended March 2014, and now own 51.10% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ACADIAN ASSET MANAGEMENT LLC Bought 2.4 Million shares of Teva Pharmaceutical Indus...